Poster Abstract Session:
256. Vaccines: RSV
Saturday, October 10, 2015: 12:30 PM-2:00 PM
Room: Poster Hall

Learning Objectives:

-

Tracks: Pediatric ID

Presentations:
Safety and immunogenicity of the recombinant live-attenuated respiratory syncytial virus vaccine RSV cps2 in RSV-seronegative infants and children
Coleen K. Cunningham, MD ; Ursula Buchholz, Ph.D. ; Petronella Muresan, MS ; Elizabeth Mcfarland, MD ; Cindy Luongo, Ph, D. ; Peter Collins, Ph.D ; Bhagvanji Thumar, Ph.D. ; Elizabeth Schappell, RN, BSN, CCRP ; Devasena Gnanashanmugam, MD ; George Siberry, MD, MPH, FPIDS ; Vivian Rexroad, Pharm.D. ; Ruth Karron, MD
Posters
  • IMPAACT P1114 ID WeekFinal.pdf (594.7 kB)
  • Development of a Live Attenuated Vaccine for Respiratory Syncytial Virus Using Codon Deoptimization of Virulence Genes and a Subgroup B Fusion Protein
    Christina Rostad, MD ; Christopher Stobart, PhD ; Anne Hotard, PhD ; Jia Meng, PhD ; Brian Gilbert, PhD ; Pedro Piedra, MD, FIDSA ; Martin Moore, PhD
    Posters
  • 09_25_15 IDSA_Rostad_final.pdf (937.8 kB)
  • High infectivity of recombinant live-attenuated respiratory syncytial virus vaccine (RSV LID ΔM2-2) in infants and children
    Elizabeth Mcfarland, MD ; Ursula Buchholz, Ph.D. ; Petronella Muresan, MS ; Coleen K. Cunningham, MD ; Cindy Luongo, Ph.D. ; Bhagvanji Thumar, Ph.D. ; Peter Collins, Ph.D ; Charlotte Perlowski, MSPH ; Elizabeth Schappell, RN, BSN, CCRP ; Devasena Gnanashanmugam, MD ; George Siberry, MD, MPH, FPIDS ; Vivian Rexroad, Pharm.D. ; Emily Barr, CPNP, CNM, MSN ; Paul Harding, MS ; Ruth Karron, MD

    CME Credits:

    ACPE Credits:

    ACPE Number:


    Findings in the abstracts are embargoed until 12:01 a.m. PDT, Wednesday Oct. 7th with the exception of research findings presented at the IDWeek press conferences.